6.1M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 110,750 | 1,997,868 (7%) | 0% | 3.6 | 394,270 | Common Stock |
| John P. Shannon | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 600,000 | 600,000 | - | - | Stock Appreciation Right | |
| John P. Shannon | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 800,000 | 2,687,118 (9%) | 2% | 0 | Common Stock | |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 110,750 | 1,887,118 (6%) | 0% | 3.6 | 394,270 | Common Stock |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 300,000 | 300,000 | - | - | Stock Appreciation Right | |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 45,909 | 1,306,885 (4%) | 0% | 3.6 | 163,436 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 98,375 | 1,208,510 (4%) | 0% | 3.6 | 350,215 | Common Stock |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 185,000 | 1,393,510 (5%) | 0% | 0 | Common Stock | |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 25,842 | 320,446 (1%) | 0% | 3.6 | 91,998 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 15,476 | 346,288 (1%) | 0% | 3.6 | 55,095 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 66,450 | 1,232,561 (4%) | 0% | 3.6 | 236,562 | Common Stock |
| Steven M. Pieper | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 185,000 | 1,417,561 (5%) | 0% | 0 | Common Stock | |
| Steven M. Pieper | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 300,000 | 300,000 | - | - | Stock Appreciation Right | |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 110,750 | 1,299,011 (4%) | 0% | 3.6 | 394,270 | Common Stock |
| Kevin McCulloch | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 29,300 | 1,548,152 (5%) | 0% | 3.6 | 104,308 | Common Stock |
| Kevin McCulloch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 500,000 | 500,000 | - | - | Stock Appreciation Right | |
| Kevin McCulloch | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 31 Jan 2025 | 48,834 | 1,499,318 (5%) | 0% | 3.6 | 173,849 | Common Stock |
| Kevin McCulloch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 185,000 | 1,684,318 (6%) | 0% | 0 | Common Stock | |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 03 Jan 2025 | 39,443 | 2,108,618 (7%) | 0% | 3.6 | 142,389 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 03 Jan 2025 | 32,039 | 1,352,794 (4%) | 0% | 3.6 | 115,661 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 03 Jan 2025 | 12,401 | 361,764 (1%) | 0% | 3.6 | 44,768 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 03 Jan 2025 | 32,059 | 1,409,761 (5%) | 0% | 3.6 | 115,733 | Common Stock |
| Kevin McCulloch | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 03 Jan 2025 | 24,501 | 1,577,452 (5%) | 0% | 3.6 | 88,449 | Common Stock |
| Steven M. Pieper | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 22 Nov 2024 | 19,483 | 1,441,820 (5%) | 0% | 1.6 | 30,199 | Common Stock |
| Steven M. Pieper | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 2,640 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven M. Pieper | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 16,843 | 0 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 12 Aug 2024 | 4,515 | 25,200 (0%) | 0% | 2.2 | 10,147 | Common Stock |
| John Schmid | Director | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 09 Aug 2024 | 4,285 | 20,685 (0%) | 0% | 2.4 | 10,134 | Common Stock |
| Kevin McCulloch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 200,000 | 200,000 | - | - | Stock Appreciation Right | |
| Kevin McCulloch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 150,000 | 1,601,953 (5%) | 0% | 0 | Common Stock | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 164,380 (0%) | 0% | 0 | Common Stock | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 890,983 (3%) | 0% | 0 | Common Stock | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 107,500 (0%) | 0% | 0 | Common Stock | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 113,159 (0%) | 0% | 0 | Common Stock | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 164,144 (0%) | 0% | 0 | Common Stock | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 107,500 (0%) | 0% | 0 | Common Stock | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 107,500 (0%) | 0% | 0 | Common Stock | |
| Ricki Louise Fairley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 135,000 (0%) | 0% | 0 | Common Stock | |
| John Schmid | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 10 May 2024 | 5,400 | 16,400 (0%) | 0% | 1.9 | 10,314 | Common Stock |
| John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.99 per share. | 18 Mar 2024 | 215,600 | 751,412 (2%) | 0% | 2.0 | 429,044 | Common Stock |
| John H. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 215,600 | 0 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2024 | 89,571 | 840,983 (3%) | 0% | - | Common Stock | |
| Garheng Kong | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2024 | 6,474 | 114,144 (0%) | 0% | - | Common Stock | |
| Jeffrey W. Sherman | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2024 | 6,502 | 114,380 (0%) | 0% | - | Common Stock | |
| John Schmid | Director | Purchase of securities on an exchange or from another person at price $ 2.16 per share. | 14 Mar 2024 | 4,500 | 11,000 (0%) | 0% | 2.2 | 9,720 | Common Stock |
| Steven M. Pieper | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 450,000 | 1,626,912 (5%) | 1% | 0 | Common Stock | |
| Johnson Ken | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 175,000 | 446,860 (1%) | 0% | 0 | Common Stock | |
| R. Edick Paul | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 1,500,000 | 3,788,064 (13%) | 5% | 0 | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 750,000 | 2,158,575 (7%) | 2% | 0 | Common Stock | |
| Edick R. Paul | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 500,000 | 500,000 | - | - | Stock Appreciation Right | |
| Beth Hecht P. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 750,000 | 1,554,968 (5%) | 2% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 09 Aug 2023 | 10,000 | 2,288,064 (8%) | 0% | 2.4 | 23,794 | Common Stock |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 107,878 (0%) | 0% | 0 | Common Stock | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 535,812 (1%) | 0% | 0 | Common Stock | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 57,500 (0%) | 0% | 0 | Common Stock | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 63,159 (0%) | 0% | 0 | Common Stock | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 107,670 (0%) | 0% | 0 | Common Stock | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 57,500 (0%) | 0% | 0 | Common Stock | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 42,500 | 57,500 (0%) | 0% | 0 | Common Stock | |
| Ricki Louise Fairley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 85,000 | 85,000 (0%) | 0% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 750,000 | 2,278,064 (8%) | 2% | 0 | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 750,000 | 1,377,806 (5%) | 2% | 0 | Common Stock | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 350,000 | 797,758 (2%) | 1% | 0 | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 150,000 | 719,780 (2%) | 0% | 0 | Common Stock | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 100,000 | 269,783 (0%) | 0% | 0 | Common Stock | |
| Steven M. Pieper | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 750,000 | 1,148,912 (4%) | 2% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 13 Dec 2022 | 20,000 | 1,528,064 (5%) | 0% | 1.5 | 29,000 | Common Stock |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 65,378 (0%) | 0% | 0 | Common Stock | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 493,312 (1%) | 0% | 0 | Common Stock | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 20,659 (0%) | 0% | 0 | Common Stock | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 65,170 (0%) | 0% | 0 | Common Stock | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 2.1 | 31,500 | Common Stock |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 12 May 2022 | 100,000 | 1,508,064 (5%) | 0% | 1.4 | 140,380 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 22 Feb 2022 | 11,228 | 569,780 (2%) | 0% | 2.4 | 27,158 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. | 22 Feb 2022 | 11,228 | 581,008 (2%) | 0% | 0.7 | 7,747 | Common Stock |
| John P. Shannon | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2022 | 300,000 | 300,000 | - | - | Stock Appreciation Right | |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 7,497 | 2,396,423 (8%) | 0% | 2.1 | 15,819 | Common Stock |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 29 Jan 2022 | 41,334 | 2,355,089 (8%) | 0% | 1.1 | 46,294 | Common Stock |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 29 Jan 2022 | 23,414 | 2,331,675 (8%) | 0% | 1.3 | 29,502 | Common Stock |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 29 Jan 2022 | 9,880 | 2,321,795 (8%) | 0% | 1.2 | 12,251 | Common Stock |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 29 Jan 2022 | 40,834 | 2,280,961 (8%) | 0% | 2.2 | 91,468 | Common Stock |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.66 per share. | 29 Jan 2022 | 22,150 | 2,258,811 (8%) | 0% | 2.7 | 58,919 | Common Stock |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 29 Jan 2022 | 110,750 | 2,148,061 (7%) | 0% | 2.5 | 272,445 | Common Stock |
| John P. Shannon | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2022 | 250,000 | 2,419,612 (8%) | 0% | 0 | Common Stock | |
| John P. Shannon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 15,692 | 2,403,920 (8%) | 0% | 2.1 | 33,110 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 4,448 | 1,540,323 (5%) | 0% | 2.1 | 9,385 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 29 Jan 2022 | 33,488 | 1,506,835 (5%) | 0% | 1.1 | 37,507 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 29 Jan 2022 | 21,177 | 1,485,658 (5%) | 0% | 1.3 | 26,683 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 29 Jan 2022 | 5,784 | 1,479,874 (5%) | 0% | 1.2 | 7,172 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 29 Jan 2022 | 33,488 | 1,446,386 (5%) | 0% | 2.2 | 75,013 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.66 per share. | 29 Jan 2022 | 19,675 | 1,426,711 (5%) | 0% | 2.7 | 52,336 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 29 Jan 2022 | 45,909 | 1,380,802 (5%) | 0% | 2.5 | 112,936 | Common Stock |
| Beth P. Hecht | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 14,037 | 1,544,771 (5%) | 0% | 2.1 | 29,618 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 2,307 | 438,136 (1%) | 0% | 2.1 | 4,868 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 29 Jan 2022 | 12,400 | 425,736 (1%) | 0% | 1.1 | 13,888 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 29 Jan 2022 | 11,029 | 414,707 (1%) | 0% | 1.3 | 13,897 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 29 Jan 2022 | 3,393 | 411,314 (1%) | 0% | 1.2 | 4,207 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 29 Jan 2022 | 12,400 | 398,914 (1%) | 0% | 2.2 | 27,776 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.66 per share. | 29 Jan 2022 | 10,747 | 388,167 (1%) | 0% | 2.7 | 28,587 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 29 Jan 2022 | 15,131 | 373,036 (1%) | 0% | 2.5 | 37,222 | Common Stock |
| Ken Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 7,497 | 440,443 (1%) | 0% | 2.1 | 15,819 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 29 Jan 2022 | 3,590 | 1,586,278 (5%) | 0% | 1.3 | 4,523 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.53 per share. | 29 Jan 2022 | 10,200 | 1,575,300 (5%) | 0% | 2.5 | 25,806 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 29 Jan 2022 | 23,067 | 1,552,233 (5%) | 0% | 2.2 | 51,670 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.66 per share. | 29 Jan 2022 | 4,379 | 1,547,854 (5%) | 0% | 2.7 | 11,648 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 29 Jan 2022 | 110,750 | 1,437,104 (5%) | 0% | 2.5 | 272,445 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.61 per share. | 29 Jan 2022 | 14,767 | 1,422,337 (5%) | 0% | 2.6 | 38,542 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 3,460 | 1,623,452 (5%) | 0% | 2.1 | 7,301 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 29 Jan 2022 | 750 | 1,622,702 (5%) | 0% | 2.1 | 1,583 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.43 per share. | 29 Jan 2022 | 9,767 | 1,612,935 (5%) | 0% | 1.4 | 13,967 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 29 Jan 2022 | 23,067 | 1,589,868 (5%) | 0% | 1.1 | 25,835 | Common Stock |
| Steven M. Pieper | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 29 Jan 2022 | 778 | 1,585,500 (5%) | 0% | 1.2 | 965 | Common Stock |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 600,000 | 1,408,064 (5%) | 2% | 0 | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 250,000 | 618,910 (2%) | 0% | 0 | Common Stock | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 225,000 | 436,821 (1%) | 0% | 0 | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 75,000 | 569,780 (2%) | 0% | 0 | Common Stock | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 75,000 | 165,865 (0%) | 0% | 0 | Common Stock | |
| Steven M. Pieper | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 200,000 | 388,834 (1%) | 0% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 15 Nov 2021 | 20,000 | 33,430 (0%) | 0% | 2.3 | 45,664 | Common Stock |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 11 Nov 2021 | 200,000 | 808,064 (2%) | 0% | 2.1 | 415,760 | Common Stock |
| John Shannon | See Remarks | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 11 Nov 2021 | 60,000 | 363,829 (1%) | 0% | 2.1 | 126,000 | Common Stock |
| John Shannon | See Remarks | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 11 Nov 2021 | 40,000 | 303,829 (1%) | 0% | 2.1 | 83,500 | Common Stock |
| Steven Pieper | See Remarks | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 10 Nov 2021 | 25,000 | 183,108 (0%) | 0% | 2.0 | 49,918 | Common Stock |
| Jeffrey W. Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 0 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 50,378 | 50,378 (0%) | 0% | - | Common Stock | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 47,040 | 47,040 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Jeffrey W. Sherman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 215,600 | 215,600 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 68,600 | 68,600 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 10,367 | 10,367 | - | - | Stock Option (Right to Buy) | |
| John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 478,312 | 478,312 (1%) | 1% | - | Common Stock | |
| Marla S. Persky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 0 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 5,659 | 5,659 (0%) | 0% | - | Common Stock | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 25,220 | 0 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 5,659 | 0 (0%) | 0% | - | Common Stock | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 25,220 | 25,220 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 50,170 | 50,170 (0%) | 0% | - | Common Stock | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 31,360 | 31,360 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 7,357 | 7,357 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,600 | 19,600 | - | - | Stock Option (Right to Buy) | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 668,065 | 668,065 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 69,822 | 69,822 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 98,252 | 98,252 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 197,231 | 197,231 (0%) | 0% | - | Common Stock | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 410,833 | 608,064 (2%) | 1% | - | Common Stock | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 197,231 | 410,833 (1%) | 0% | - | Common Stock | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 410,833 | 0 (0%) | 1% | - | Common Stock | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 13,430 | 0 (0%) | 0% | - | Common Stock | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 668,065 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 69,822 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 98,252 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 400,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 13,430 | 13,430 (0%) | 0% | - | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 28,072 | 28,072 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 34,977 | 0 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 28,072 | 0 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 25,136 | 0 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 70,496 | 70,496 (0%) | 0% | - | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 193,333 | 263,829 (0%) | 0% | - | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 160,335 | 160,335 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 25,136 | 25,136 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 34,977 | 34,977 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 160,335 | 0 | - | - | Stock Option (Right to Buy) | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 193,333 | 0 (0%) | 0% | - | Common Stock | |
| John Shannon | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 70,496 | 193,333 (0%) | 0% | - | Common Stock | |
| B. J. Bormann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 0 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 26,366 | 26,366 (0%) | 0% | - | Common Stock | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 65,295 | 0 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 30,879 | 0 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 180,000 | 0 (0%) | 0% | - | Common Stock | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 26,366 | 180,000 (0%) | 0% | - | Common Stock | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 32,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 3,826 | 3,826 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 65,295 | 65,295 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 30,879 | 30,879 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 180,000 | 206,366 (0%) | 0% | - | Common Stock | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 3,826 | 0 | - | - | Stock Option (Right to Buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 0 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 19,650 | 19,650 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 28,072 | 28,072 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 384,780 | 110,000 (0%) | 1% | - | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 110,000 | 0 (0%) | 0% | - | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 28,072 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,266 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 14,036 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 384,780 | 384,780 (1%) | 1% | - | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 110,000 | 494,780 (1%) | 0% | - | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,266 | 11,266 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 14,036 | 14,036 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 21,401 | 21,401 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 5,280 | 0 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 33,686 | 0 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 78,333 | 0 (0%) | 0% | - | Common Stock | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 11,250 | 78,333 (0%) | 0% | - | Common Stock | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 11,250 | 11,250 (0%) | 0% | - | Common Stock | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 39,633 | 39,633 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 5,280 | 5,280 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 33,686 | 33,686 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 78,333 | 89,583 (0%) | 0% | - | Common Stock | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 32,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 21,401 | 0 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 39,633 | 0 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 23,775 | 134,333 (0%) | 0% | - | Common Stock | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 23,775 | 23,775 (0%) | 0% | - | Common Stock | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 134,333 | 158,108 (0%) | 0% | - | Common Stock | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 16,843 | 16,843 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 2,640 | 2,640 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 14,036 | 14,036 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 27,891 | 27,891 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 27,891 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 14,036 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 2,640 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 16,843 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Pieper | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Oct 2021 | 134,333 | 0 (0%) | 0% | - | Common Stock | |
| Steven Pieper | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 100,000 | 158,858 (0%) | 0% | 0 | Common Stock | |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,228 | 11,228 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.07 per share. | 12 Apr 2021 | 10,000 | 496,824 (1%) | 0% | 4.1 | 40,725 | Common Stock |
| Barry M. Deutsch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 115,000 | 208,090 (0%) | 0% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 225,000 | 636,134 (2%) | 0% | 0 | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 150,000 | 271,224 (0%) | 0% | 0 | Common Stock | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 150,000 | 210,814 (0%) | 0% | 0 | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 100,000 | 506,824 (1%) | 0% | 0 | Common Stock | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 65,000 | 91,890 (0%) | 0% | 0 | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.01 per share. | 13 Jan 2021 | 10,000 | 406,824 (1%) | 0% | 6.0 | 60,058 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.72 per share. | 11 Jan 2021 | 10,000 | 416,824 (1%) | 0% | 5.7 | 57,244 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2020 | 10,000 | 426,824 (1%) | 0% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.06 per share. | 09 Dec 2020 | 10,000 | 411,134 (1%) | 0% | 4.1 | 40,551 | Common Stock |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Barry M. Deutsch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Beth Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Barry M. Deutsch | See Remarks | Grant, award, or other acquisition of securities at price $ 2.26 per share. | 30 Jun 2020 | 3,731 | 93,090 (0%) | 0% | 2.3 | 8,432 | Common Stock |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 2.26 per share. | 30 Jun 2020 | 3,731 | 121,224 (0%) | 0% | 2.3 | 8,432 | Common Stock |
| Beth Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 2.26 per share. | 30 Jun 2020 | 3,731 | 60,814 (0%) | 0% | 2.3 | 8,432 | Common Stock |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 2.26 per share. | 30 Jun 2020 | 775 | 26,890 (0%) | 0% | 2.3 | 1,752 | Common Stock |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 11,228 | 11,228 | - | - | Stock Option (right to buy) | |
| Mark A. Thierer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 11,228 | 11,228 | - | - | Stock Option (right to buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 11,228 | 11,228 | - | - | Stock Option (right to buy) | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 11,228 | 11,228 | - | - | Stock Option (right to buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 11,228 | 11,228 | - | - | Stock Option (right to buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 11,228 | 11,228 | - | - | Stock Option (right to buy) | |
| John Shannon | See Remarks | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 13 May 2020 | 22,000 | 117,493 (0%) | 0% | 3.5 | 77,994 | Common Stock |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 08 May 2020 | 33,000 | 401,134 (1%) | 0% | 3 | 99,000 | Common Stock |
| John Shannon | See Remarks | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 08 May 2020 | 7,886 | 95,493 (0%) | 0% | 3.2 | 25,219 | Common Stock |
| Beth Hecht | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 13 Mar 2020 | 4,000 | 57,083 (0%) | 0% | 2.0 | 7,880 | Common Stock |
| Barry M. Deutsch | See Remarks | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 14 Feb 2020 | 9,639 | 39,359 (0%) | 0% | 4.2 | 40,002 | Common Stock |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 14 Feb 2020 | 20,000 | 183,134 (0%) | 0% | 4.2 | 83,000 | Common Stock |
| John Shannon | See Remarks | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 14 Feb 2020 | 12,048 | 22,607 (0%) | 0% | 4.1 | 49,999 | Common Stock |
| Beth Hecht | See Remarks | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 14 Feb 2020 | 4,000 | 8,083 (0%) | 0% | 4.2 | 16,600 | Common Stock |
| Ken Johnson | See Remarks | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 14 Feb 2020 | 2,410 | 6,115 (0%) | 0% | 4.2 | 10,002 | Common Stock |
| Barry M. Deutsch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 50,000 | 89,359 (0%) | 0% | 0 | Common Stock | |
| Paul R. Edick | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.37 per share. | 31 Jan 2020 | 9,801 | 163,134 (0%) | 0% | 6.4 | 62,432 | Common Stock |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 185,000 | 368,134 (1%) | 0% | 0 | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 65,000 | 87,607 (0%) | 0% | 0 | Common Stock | |
| Beth Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 45,000 | 53,083 (0%) | 0% | 0 | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 15,000 | 436,824 (1%) | 0% | 0 | Common Stock | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2020 | 20,000 | 26,115 (0%) | 0% | 0 | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.50 per share. | 13 Jan 2020 | 10,000 | 421,824 (1%) | 0% | 5.5 | 54,992 | Common Stock |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 5.99 per share. | 31 Dec 2019 | 438 | 10,559 (0%) | 0% | 6.0 | 2,624 | Common Stock |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 5.99 per share. | 31 Dec 2019 | 459 | 4,083 (0%) | 0% | 6.0 | 2,749 | Common Stock |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 5.99 per share. | 31 Dec 2019 | 286 | 3,705 (0%) | 0% | 6.0 | 1,713 | Common Stock |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 25 Nov 2019 | 17,935 | 172,935 (0%) | 0% | 8.5 | 153,283 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2019 | 17,500 | 431,824 (1%) | 0% | 0 | Common Stock | |
| Mark A. Thierer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2019 | 19,650 | 19,650 | - | - | Stock Option (right to buy) | |
| Barry M. Deutsch | See Remarks | Grant, award, or other acquisition of securities at price $ 9.72 per share. | 01 Jul 2019 | 1,428 | 29,720 (0%) | 0% | 9.7 | 13,880 | Common Stock |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 9.72 per share. | 01 Jul 2019 | 1,138 | 10,121 (0%) | 0% | 9.7 | 11,061 | Common Stock |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 9.72 per share. | 01 Jul 2019 | 174 | 3,419 (0%) | 0% | 9.7 | 1,691 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.56 per share. | 11 Apr 2019 | 10,000 | 477,024 (1%) | 0% | 9.6 | 95,649 | Common Stock |
| Paul R. Edick | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 9.12 per share. | 11 Mar 2019 | 30,000 | 155,000 (0%) | 0% | 9.1 | 273,585 | Common Stock |
| Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Jonathan Rigby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Barry M. Deutsch | See Remarks | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 19 Feb 2019 | 5,000 | 28,292 (0%) | 0% | 10 | 50,000 | Common Stock |
| Beth P. Hecht | See Remarks | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 19 Feb 2019 | 2,500 | 2,500 (0%) | 0% | 10 | 25,000 | Common Stock |
| Ken Johnson | See Remarks | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 19 Feb 2019 | 1,000 | 3,245 (0%) | 0% | 10 | 10,000 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 08 Feb 2019 | 5,890 | 857,821 (3%) | 0% | 15.1 | 88,986 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Feb 2019 | 1,351 | 856,470 (3%) | 0% | 15 | 20,265 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 05 Feb 2019 | 4,998 | 873,520 (3%) | 0% | 15.1 | 75,308 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 05 Feb 2019 | 9,409 | 863,711 (3%) | 0% | 15 | 141,135 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 05 Feb 2019 | 400 | 873,120 (3%) | 0% | 15 | 6,000 | Common Stock |
| Barry M. Deutsch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Paul R. Edick | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 125,000 | 125,000 (0%) | 0% | 0 | Common Stock | |
| John Shannon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Beth P. Hecht | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Steven Prestrelski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Ken Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2019 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Jan 2019 | 828 | 884,728 (3%) | 0% | 15 | 12,420 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 28 Jan 2019 | 6,210 | 878,518 (3%) | 0% | 15.1 | 94,028 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 16.35 per share. | 23 Jan 2019 | 32,199 | 967,801 (3%) | 0% | 16.3 | 526,376 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 23 Jan 2019 | 5,425 | 962,376 (3%) | 0% | 15.0 | 81,563 | Common Stock |
| Flynn E James | Other, Possible Member of 10% Group | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 23 Jan 2019 | 76,820 | 885,556 (3%) | 0% | 15.1 | 1,158,254 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 14 Jan 2019 | 9,962 | 459,362 (1%) | 0% | 12.0 | 119,913 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.20 per share. | 14 Jan 2019 | 7,700 | 469,324 (1%) | 0% | 17.2 | 132,459 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.71 per share. | 14 Jan 2019 | 38 | 459,324 (1%) | 0% | 12.7 | 483 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.97 per share. | 14 Jan 2019 | 10,000 | 449,324 (1%) | 0% | 8.0 | 79,746 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Jan 2019 | 2,300 | 487,024 (1%) | 0% | - | Common Stock | |
| Steven Prestrelski | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 24 Dec 2018 | 15,720 | 489,324 (2%) | 0% | 15.8 | 248,738 | Common Stock |
| Steven Prestrelski | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2018 | 15,720 | 0 | - | - | Stock Option (Right to Buy) | |
| Steven Prestrelski | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 24 Dec 2018 | 15,720 | 505,044 (2%) | 0% | 1.2 | 18,707 | Common Stock |
| Barry M. Deutsch | Chief Financial Officer | 25 Jun 2018 | 3,987 | 0 | - | - | Series C Preferred Stock | ||
| Barry M. Deutsch | Chief Financial Officer | 25 Jun 2018 | 2,238 | 23,292 (0%) | 0% | 0 | Common Stock | ||
| Flynn E James | Other | 25 Jun 2018 | 1,557,292 | 0 | - | - | Series C Preferred Stock | ||
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 25 Jun 2018 | 624,333 | 1,498,666 (7%) | 3% | 15 | 9,364,995 | Common Stock |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 25 Jun 2018 | 125,667 | 1,000,000 (4%) | 0% | 15 | 1,885,005 | Common Stock |
| Flynn E James | Other | 25 Jun 2018 | 874,333 | 874,333 (4%) | 4% | 0 | Common Stock | ||
| Flynn E James | Other | 25 Jun 2018 | 874,333 | 874,333 (4%) | 4% | 0 | Common Stock | ||
| Flynn E James | Other | 25 Jun 2018 | 1,557,292 | 0 | - | - | Series C Preferred Stock | ||
| Paul R. Edick | Director, See Remarks | 25 Jun 2018 | 23,922 | 0 | - | - | Series C Preferred Stock | ||
| Paul R. Edick | Director, See Remarks | 25 Jun 2018 | 13,430 | 13,430 (0%) | 0% | 0 | Common Stock | ||
| John Shannon | See Remarks | 25 Jun 2018 | 16,000 | 0 | - | - | Series C Preferred Stock | ||
| John Shannon | See Remarks | 25 Jun 2018 | 8,983 | 8,983 (0%) | 0% | 0 | Common Stock | ||
| Steven Prestrelski | Chief Scientific Officer | 25 Jun 2018 | 30,232 | 482,193 (2%) | 0% | 0 | Common Stock | ||
| Steven Prestrelski | Chief Scientific Officer | 25 Jun 2018 | 7,130 | 489,323 (2%) | 0% | 0 | Common Stock | ||
| Steven Prestrelski | Chief Scientific Officer | 25 Jun 2018 | 12,701 | 0 | - | - | Series B Preferred Stock | ||
| Steven Prestrelski | Chief Scientific Officer | 25 Jun 2018 | 53,849 | 0 | - | - | Series A Preferred Stock | ||
| Ken Johnson | See Remarks | 25 Jun 2018 | 4,000 | 0 | - | - | Series C Preferred Stock | ||
| Ken Johnson | See Remarks | 25 Jun 2018 | 2,245 | 2,245 (0%) | 0% | 0 | Common Stock |